Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date13 Oct 2021 |
100 Clinical Results associated with CHENGDE NEW AIMIN PHARMACEUTICAL CO.,LTD
0 Patents (Medical) associated with CHENGDE NEW AIMIN PHARMACEUTICAL CO.,LTD
100 Deals associated with CHENGDE NEW AIMIN PHARMACEUTICAL CO.,LTD
100 Translational Medicine associated with CHENGDE NEW AIMIN PHARMACEUTICAL CO.,LTD